Emergent BioSolutions Receives Health Canada Approval of BioThrax® (Anthrax Vaccine Adsorbed)
Emergent Biosolutions Inc
Quote +/-
46.33 -0.04 60.87
18-12-2018 02:35

GAITHERSBURG, Md., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that Health Canada has approved the company’s New Drug Submission (NDS) for its anthrax vaccine, BioThrax® (Anthrax Vaccine Adsorbed). BioThrax is indicated for active immunization for the prevention of disease caused by Bacillus anthracis, in individ...


Thanks for sharing this wonderful thing. Let's continue to share more useful and visible things like this. Thank you very much Temple run
DeletedUser 0
18-12-2018 02:36